CBE ID
3686
Endorsement Status
1.1 New or Maintenance
Previous Endorsement Cycle
Is Under Review
No
Next Maintenance Cycle
Fall 2027
1.3 Measure Description
Risk-adjusted ratio of observed bacteremias and fungemias to predicted bacteremias and fungemias among patients previously admitted to acute care hospitals.
-
-
1.5 Measure Type
-
1.14 Numerator
Observed bacteremia and fungemia among patients previously admitted to acute care hospitals.
-
1.15 Denominator
The HOB measure denominator is the predicted number of HOB events in an acute care hospital based on predictive models using facility-level and patient-level factors.
-
OLD 1.12 MAT output not attachedAttached1.13a Data dictionary not attachedNo
-
Most Recent Endorsement ActivityEndorsed Patient Safety Fall 2022Initial EndorsementLast Updated
-
StewardCenters for Disease Control and PreventionSteward Organization POC EmailMeasure Developer Secondary Point Of Contact
United States
-
-
-
Risk adjustment approachOffRisk adjustment approachOffConceptual model for risk adjustmentOffConceptual model for risk adjustmentOff
-
Effective March 27, 2023, the National Quality Forum (NQF) is no longer the consensus-based entity (CBE) funded through the Centers for Medicare & Medicaid Services (CMS) National Consensus Development and Strategic Planning for Health Care Quality Measurement Contract. Battelle has been selected to oversee the endorsement & maintenance (E&M) of clinical quality and cost/resource use measures. Since the Fall 2022 cycle launched at NQF, measures submitted to this E&M cycle continued along the prior E&M protocols that were in place at time of the Fall 2022 “Intent to Submit.” Battelle took over the E&M work for the Fall 2022 cycle after developers and/or stewards submitted their full measure information to NQF, which for CBE #3686, the most recent measure specifications can be found here: https://p4qm.org/sites/default/files/2024-02/3686.zip
Battelle took over the E&M work beginning with the public comment period to close the E&M committees for the post-comment meeting, convening the CSAC to render a final endorsement decision, and executing the appeals period.